Skip to main content
. Author manuscript; available in PMC: 2020 Dec 26.
Published in final edited form as: J Alzheimers Dis. 2019;71(Suppl 1):S95–S103. doi: 10.3233/JAD-181227

Table 2.

Clinical gait abnormalities by MCR status

Gait Abnormalities Any MCR Subtype (n = 81) MCRv (n = 43) MCRsl (n = 41) MCRsw (n = 21) MCRslv (n = 24) MCRswv (n = 25)
Any abnormality (n = 52) 52 (64.2) 34 (79.1) 33 (80.5) 11 (52.4) 14 (58.3) 14 (56.0)
Neurological gait (n = 28) 28 (34.6) 19 (44.2) 19 (46.3) 5 (23.8) 9 (37.5) 6 (24.0)
Non-Neurological gait (n = 39) 39 (48.1) 26 (60.5) 24 (58.5) 11 (52.4) 8 (33.3) 10 (40.0)
Severity of gait abnormality
Mild (n = 44) 44 (54.3) 26 (60.5) 25 (61.0) 10 (47.6) 11 (45.8) 11 (44.0)
Moderate (n = 8) 8 (9.9) 8 (18.6) 8 (19.5) 1 (4.8) 3 (12.5) 3 (12.0)
Neurological gait subtype
Parkinsonian (n = 1) 1 (1.2) 1 (2.3) 1 (2.4) 0 1 (4.2) 0
Ataxic (n = 2) 2 (2.5) 1 (2.3) 2 (4.9) 1 (4.8) 0 0
Unsteady (n = 6) 6 (7.4) 3 (7.0) 4 (9.8) 1 (4.8) 4 (16.7) 1 (4.0)
Spastic/stiff (n = 2) 2 (2.5) 1 (2.3) 1 (2.4) 0 1 (4.2) 0
Neuropathic (n = 17) 17 (21.0) 13 (30.2) 11 (26.8) 3 (14.3) 3 (12.5) 5 (20.0)
Non-neurological gait subtype
Arthritis (n = 25) 25 (30.9) 18 (41.9) 16 (39.0) 7 (33.3) 7 (29.2) 5 (20.0)
Joint deformity (n = 5) 5 (6.2) 2 (4.7) 2 (4.9) 2 (9.5) 0 2 (8.0)
Respiratory (n = 1) 1 (1.2) 1 (2.3) 1 (2.4) 0 0 0
Other (n = 8) 4 (9.9) 5 (11.6) 5 (12.2) 2 (9.5) 1 (4.2) 3 (12.0)

MCR, motoric cognitive risk; MCRv, MCR velocity; MCRsl, MCR stride length; MCRsw, MCR swing time; MCRslv, MCR stride length variability; MCRswv, MCR swing time variability.